Smith Group Asset Management, LLC Pacira Bio Sciences, Inc. Transaction History

Smith Group Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$25.5 - $31.51 $1,071 - $1,323	42 Added 0.58%	7,251 $207 Million
Q1 2024 Apr 30, 2024	BUY	$27.7 - $35.48 $199,689 - $255,775	7,209 New	7,209 $211 Million
Q4 2023 Feb 12, 2024	SELL	$26.32 - $34.31 $134,416 - $175,221	-5,107 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$60.03 - $76.49 $226,133 - $288,137	-3,767 Reduced 42.45%	5,107 $390,000
Q4 2021 Feb 02, 2022	SELL	$47.97 - $62.21 $10,841 - $14,059	-226 Reduced 2.48%	8,874 $534,000
Q3 2021 Nov 12, 2021	BUY	$54.64 - $61.3 $497,224 - $557,830	9,100 New	9,100 $510,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Smith Group Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Smith Group Asset Management, LLC with notifications on news.